1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Dapgliflozin
Trade Name:
Forxiga
Manufacturer/Distributor:
AstraZeneca Canada
Classification:
Sodium-glucose contransporter 2 (SGLT2) inhibitor
ATC Class:
A10BX - other oral blood glucose lowering agent
Status:
active
Notice of Compliance (yyyy/mm/dd):
2014/12/12
Date Marketed in Canada (yyyy/mm/dd):
2016/02/10
Presentation:
Tablet: 5 mg. DIN: 02435462
Tablet: 10 mg. DIN: 02435470
Comments:
As monotherapy in adjunct to diet and exercise to improve glycemic contril in adults with type 2 diabetes for whom metformin is inappropriate due to contraindications or intolerance. Can also be used as add-on combination with other diabetes medications.
Back to:
Drug Product Listings 
